These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21384242)

  • 1. Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database.
    Burr AT; Li Y; Tseng JF; Saidi RF; Bozorgzadeh A; Shah SA
    World J Surg; 2011 Jul; 35(7):1590-5. PubMed ID: 21384242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of liver grafts procured from hepatitis C-positive donors.
    Velidedeoglu E; Desai NM; Campos L; Olthoff KM; Shaked A; Nunes F; Zeldin G; Stewart C; Blumberg E; Abrams J; Markmann JF
    Transplantation; 2002 Feb; 73(4):582-7. PubMed ID: 11889435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.
    Ghobrial RM; Steadman R; Gornbein J; Lassman C; Holt CD; Chen P; Farmer DG; Yersiz H; Danino N; Collisson E; Baquarizo A; Han SS; Saab S; Goldstein LI; Donovan JA; Esrason K; Busuttil RW
    Ann Surg; 2001 Sep; 234(3):384-93; discussion 393-4. PubMed ID: 11524591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant model to predict posttransplant survival in liver transplant patients.
    Ghobrial RM; Gornbein J; Steadman R; Danino N; Markmann JF; Holt C; Anselmo D; Amersi F; Chen P; Farmer DG; Han S; Derazo F; Saab S; Goldstein LI; McDiarmid SV; Busuttil RW
    Ann Surg; 2002 Sep; 236(3):315-22; discussion 322-3. PubMed ID: 12192318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Retransplantation for Recurrence of HCV-Related Cirrhosis Using Hepatitis C-Positive Allografts: A 19-Year OPTN Analysis.
    Torosian JC; Leiby BE; Fenkel JM; Frank AM; Ramirez CG; Doria C
    Ann Transplant; 2016 May; 21():262-9. PubMed ID: 27137953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of donor age on the results of liver transplantation in hepatitis C virus-positive recipients.
    Pérez-Daga JA; Ramírez-Plaza C; Suárez MA; Santoyo J; Fernández-Aguilar JL; Aranda JM; Sánchez-Pérez B; González-Sánchez A; Alvárez A; Valle M; Bondía JA
    Transplant Proc; 2008 Nov; 40(9):2959-61. PubMed ID: 19010159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher thresholds for the utilization of steatotic allografts in liver transplantation: Analysis from a U.S. national database.
    Steggerda JA; Bloom MB; Noureddin M; Brennan TV; Todo T; Nissen NN; Klein AS; Kim IK
    PLoS One; 2020; 15(4):e0230995. PubMed ID: 32240235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor risk factors in orthotopic liver transplant: analysis of the OPTN/UNOS registry.
    Kawakita S; Everly MJ
    Clin Transpl; 2013; ():13-22. PubMed ID: 25095488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation.
    Cotter TG; Aronsohn A; Reddy KG; Charlton M
    Transplantation; 2021 Jun; 105(6):1285-1290. PubMed ID: 32639400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients.
    Velidedeoglu E; Mange KC; Frank A; Abt P; Desai NM; Markmann JW; Reddy R; Markmann JF
    Transplantation; 2004 Jun; 77(12):1834-42. PubMed ID: 15223900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthotopic liver transplant using allografts from geriatric population in the United States: is there any age limit?
    Singhal A; Sezginsoy B; Ghuloom AE; Hutchinson IV; Cho YW; Jabbour N
    Exp Clin Transplant; 2010 Sep; 8(3):196-201. PubMed ID: 20716036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
    Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
    Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor diabetes mellitus is an independent risk factor for graft loss in HCV positive but not HCV negative liver transplant recipients.
    Wu Y; Ahmed A; Kamal A
    Dig Dis Sci; 2013 Feb; 58(2):574-8. PubMed ID: 22923335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.